Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-59
SponsorBurapha University
About this trial
This study consists of two sub-studies. Study 1 investigates gene expression related to the development of hypertension in Thailand, and Study 2 examines the effectiveness of the 4-7-8 breathing technique in reducing blood pressure in individuals with hypertension.
Eligibility criteria
Qualifiers
Group of individuals with hypertension
Male or female
Aged between 18-59 years
Of Thai ethnicity
Disqualifiers
Has heart disease, such as valvular stenosis or regurgitation, coronary artery disease, or heart failure
Has obesity, defined as having a body mass index (BMI) of 30 kg/m² or higher
Has a fever or is currently experiencing an infectious disease, such as COVID-19, the flu, or other infections
Group of individuals with normal blood pressure
Trial design
Treatments tested in this trial
- Study 2: deep breathing
- Study 2: 4-7-8 breathing
- Study 2: slow breathing with device
Treatment groups
200 Participants
are divided into 4 treatment groupsLocations
1Faculty of Allied Health Sciences, Burapha University20131, MueangChonburiChangwat Chon Buri, Thailand
Sponsors and collaborators
Burapha University
Lead sponsor
Source ClinicalTrials.gov